Expression and promoter methylation of Apaf-1 gene in laryngeal squamous cell carcinoma

Acta Genetica Sinica

Volumn 31, Issue 12, 2004, Pages 1327-1331

  Huang, Dai Fa ^a,b   Fu, Wei Neng ^a   Shang, Chao ^a   Xu, Zhen Ming ^c   Li, Zeng Gang ^a   Sun, Kai Lai ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

^b GENERAL HOSPITAL OF NORTHERN THEATER COMMAND   (China)

^c The 463 Hospital of Chinese PLA   (China)

Author keywords

Apaf 1 gene; Comparative genomic hybrodization (CGH); Laryngeal squamous cell carcinoma (LSCC); Loss of heterozygosity (LOH); Methylation; Semi quantitative RT PCR

Indexed keywords

APOPTOTIC PROTEASE ACTIVATING FACTOR 1; CYTOCHROME C; DNA; GENE PRODUCT; MESSENGER RNA; RNA;

APAF 1 GENE; APOPTOSIS; APOPTOSIS ASSOCIATED GENE; ARTICLE; CARCINOGENESIS; CHROMOSOME 12Q; COMPARATIVE GENOMIC HYBRIDIZATION; DNA METHYLATION; GENE; GENE AMPLIFICATION; GENE DELETION; GENE EXPRESSION; GENE LOSS; GENETIC TRANSCRIPTION; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; LARYNX CARCINOMA; LARYNX SQUAMOUS CELL CARCINOMA; PARANEOPLASTIC LARYNX TISSUE; PROMOTER REGION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEMIQUANTITATIVE REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SQUAMOUS CELL CARCINOMA; TISSUE; TUMOR SUPPRESSOR GENE;

APOPTOTIC PROTEASE-ACTIVATING FACTOR 1; CARCINOMA, SQUAMOUS CELL; CHROMOSOMES, HUMAN, PAIR 12; CPG ISLANDS; DNA METHYLATION; HUMANS; LARYNGEAL NEOPLASMS; PROMOTER REGIONS (GENETICS); PROTEINS;

EID: 10844250903     PISSN: 03794172     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Barnard D, Lehmann K, Hoal E G, van Helden P D, Victor T C. The spectrum of mutations in TP53 in laryngeal cancer patients from a high-incidence population shows similarities to many of the known mutational hotspots. Cancer Genet Cytogenet, 2003, 145 (2): 126-132.
2. Yu S W, Wang H, Poitras M F, Coombs C, Bowers W J, Federoff H J, Poirier G G, Dawson T M, Dawson V L. Mediation of poly (ADP-ribose) polymerase-1- dependent cell death by apoptosis-inducing factor. Science, 2002, 297 (5579): 259-263.
3. Juvekar A S, Amonkar A J, D'cruz A K, Saikaia T, Pradhan S. Chemosensitivity of advanced larynx carcinoma cells in vitro and significance of multidrug resistance markers in these tumors. Cancer Biother Radiopharm, 1998; 13 (2): 81-87.
4. Johnstone R W, Ruefli A A, Lowe S W. Apoptosis: a link between cancer genetics and chemotherapy. Cell, 2002, 108: 153-164.
5. GUO Rui, HUANG De-Liang, YANG Wei-Yan, HAN Dong-Yi. Significance of p53, c-myc and nm23 protein expression in recurrent laryngeal carcinoma. J Clin Otorhinolaryngology, 2003, 17 (3): 161-163.
6. QIU Guang-Bin, HE Guang, GONG Li-Guo, ZHAO Zhen, PAN Zi-Min, TANG Yu-Chai, SUN Kai-Lai. Cloning of hTERT cDNA fragment and application of anti-hTERT monoclonal antibody in mechanism of laryngeal carcinogenesis. Acta Genetica Sinica, 2003, 30 (2): 109-113.
7. Soengas M S, Alarcon R M, Yoshida H, Giaccia A J, Hakem R, Mak T W, Lowe S W. Apaf-1 and Caspase-9 in p53-dependent apoptosis and tumor inhibition. Science, 1999, 284: 156-159.
8. Soengas M S, Capodieci P, Polsky D, Mora J, Esteller M, Opitz-Araya X, McCombie R, Herman J G, Gerald W L, Lazebnik Y A, Cordon-Cardo C, Lowe S W. Inactivation of the apoptosis effector Apaf-1 in malignant melanoma. Nature, 2001, 409: 207-211.
9. Fu W N, Bertoni F, Kelsey S M, McElwaine S M, Cotter F E, Newland A C, Jia L. Role of DNA methylation in the suppression of Apaf-1 protein in human leukaemia. Oncogene, 2003, 22: 451-455.
10. Barnard D, Lehmann K, Hoal E G, van Helden P D, Victor T C. The spectrum of mutations in TP53 in laryngeal cancer patients from a high-incidence population shows similarities to many of the known mutational hotspots. Cancer Genet Cytogenet, 2003, 145 (2): 126-132.
11. Herman J G, Baylin S B. Gene silencing in cancer in association with promoter hypermethylation. N Engl J Med, 2003, 349: 2042-2054.